Table 1 Number and proportion of patients diagnosed with gout or asymptomatic hyperuricemia who received ULT
| Â | Â | Age | Â | Â |
|---|---|---|---|---|
Total | 0–5 years | 6–11 years | 12–18 years | |
All | ||||
All | ||||
 Diagnosed, n | 276 | 22 | 43 | 211 |
 Treated, n (%) | 97 (35.1) | 1 (4.5) | 10 (23.3) | 86 (40.8) |
Gout | ||||
 Diagnosed, n | 48 | 3 | 7 | 38 |
 Treated, n (%) | 18 (37.5) | 0 (0.0) | 1 (14.3) | 17 (44.7) |
Asymptomatic hyperuricemia | ||||
 Diagnosed, n | 228 | 19 | 36 | 173 |
 Treated, n (%) | 79 (34.6) | 1 (5.3) | 9 (25.0) | 69 (39.9) |
Male | ||||
All | ||||
 Diagnosed, n | 209 | 10 | 23 | 176 |
 Treated, n (%) | 83 (39.7) | 1 (10.0) | 6 (26.1) | 76 (43.2) |
Gout | ||||
 Diagnosed, n | 33 | 1 | 2 | 30 |
 Treated, n (%) | 16 (48.5) | 0 (0.0) | 0 (0.0) | 16 (53.3) |
Asymptomatic hyperuricemia | ||||
 Diagnosed, n | 176 | 9 | 21 | 146 |
 Treated, n (%) | 67 (38.1) | 1 (11.1) | 6 (28.6) | 60 (41.1) |
Female | ||||
All | ||||
 Diagnosed, n | 67 | 12 | 20 | 35 |
 Treated, n (%) | 14 (20.9) | 0 (0.0) | 4 (20.0) | 10 (28.6) |
Gout | ||||
 Diagnosed, n | 15 | 2 | 5 | 8 |
 Treated, n (%) | 2 (13.3) | 0 (0.0) | 1 (20.0) | 1 (12.5) |
Asymptomatic hyperuricemia | ||||
 Diagnosed, n | 52 | 10 | 15 | 27 |
 Treated, n (%) | 12 (23.1) | 0 (0.0) | 3 (20.0) | 9 (33.3) |